Lifecare ASA (OSL:LIFE)

Market Cap	122.06M
Revenue (ttm)	9.26M
Net Income (ttm)	-78.98M
Shares Out	15.85M
EPS (ttm)	-5.67
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	106,760
Average Volume	62,747
Open	8.00
Previous Close	7.70
Day's Range	6.50 - 8.00
52-Week Range	6.96 - 35.95
Beta	-0.53
RSI	35.72
Earnings Date	May 15, 2025

About Lifecare ASA

Lifecare ASA, together with its subsidiaries, operates as a medical sensor company that develops technology for sensing and monitoring of various body analytes in Norway. The company develops Sencell, a micro sensor for monitoring glucose levels in patients with diabetes and for veterinary applications. It also develops and manufactures a nanostrain biosensor, an ultra-small device that measures pressure, temperature, force, or various other performance indicators in live tissue; and medical devices that remove subdermal implants. Lifecare ASA ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2006
• Employees: 39
• Stock Exchange: Oslo Børs
• Ticker Symbol: LIFE

Financial Performance

In 2024, Lifecare ASA's revenue was 9.67 million, a decrease of -26.10% compared to the previous year's 13.09 million. Losses were -71.76 million, 103.5% more than in 2023.